China Isotope & Radiation Joins CNNC-Led Nuclear Technology Investment Fund - The Globe and Mail

Oklo Inc. OKLO is advancing its plans to establish a domestic isotope supply chain through its Groves-1 Isotope Test Reactor in Texas. The facility is designed to support the development of isotopes used in cancer treatments, manufacturing, scientific research and national security. The project has already cleared important regulatory and operational milestones, including startup authorization from the U. S. Department of Energy (“DOE”) on July 23, 2026, and first criticality on Aug. 5, 2026. OKLO developed Groves on privately owned land using private funding and commercially sourced equipment, alongside components manufactured by the company. The facility reached first criticality in just over 11 months from groundbreaking, with substantial construction completed in 229 days. The project provided experience in reactor construction, equipment installation, regulatory reviews and nuclear operations. Management plans to apply these lessons to future isotope facilities, potentially improving project execution and shortening development timelines. OKLO is also strengthening its isotope supply chain.

Upgrading to a WiFi 7 router just got easier PC Guide is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Read More

Here’s your NYT Strands hint for today, plus the spangram and all of today’s Strands answers for puzzle No. 959 on Sunday, Oct. 18, 2026. Today’s Strands theme was tricky. It helps to be a runner. Read on for all the answers.